Morning Briefing
Summaries of health policy coverage from major news organizations
New Rules On 'Off-Label' Drug Marketing Expected
The FDA is reviewing what kind of data drug companies should be allowed to give doctors about off-label uses with a goal of issuing guidelines by year's end.
This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
